[HTML][HTML] Connexins as therapeutic targets in neurological and neuropsychiatric disorders

M Charvériat, F Mouthon, W Rein… - Biochimica et Biophysica …, 2021 - Elsevier
Astrocytes represent the reticular part of the central nervous system; gap junctions formed by
connexins Cx43, Cx30-and Cx26 provide for homocellular astrocyte-astrocyte coupling …

Modeling and targeting neuroglial interactions with human pluripotent stem cell models

J Bigarreau, N Rouach, AL Perrier, F Mouthon… - International Journal of …, 2022 - mdpi.com
Generation of relevant and robust models for neurological disorders is of main importance
for both target identification and drug discovery. The non-cell autonomous effects of glial …

Targeting connexins: possible game changer in managing neuropathic pain?

Y Su, A Verkhratsky, C Yi - Trends in Molecular Medicine, 2024 - cell.com
Neuropathic pain is a chronic debilitating condition caused by nerve injury or a variety of
diseases. At the core of neuropathic pain lies the aberrant neuronal excitability in the …

Pharmaco-fUS for characterizing drugs for Alzheimer's disease–the case of THN201, a drug combination of donepezil plus Mefloquine

B Vidal, M Droguerre, M Valdebenito… - Frontiers in …, 2020 - frontiersin.org
Donepezil is a potent acetylcholinesterase inhibitor, largely used worldwide to alleviate
cognitive symptoms in Alzheimer's disease (AD). Beyond the widely described neuronal …

RETRACTED ARTICLE: Vitamin D alleviates cognitive dysfunction and brain damage induced by copper sulfate intake in experimental rats: focus on its combination …

MM Elseweidy, M Mahrous, SI Ali, MA Shaheen… - Naunyn-Schmiedeberg's …, 2023 - Springer
This study aimed to demonstrate the potential benefits of donepezil (DPZ) and vitamin D (Vit
D) in combination to counteract the neurodegenerative disorders induced by CuSO4 intake …

Impact of Donepezil on Brain Glucose Metabolism Assessed Using [18F]2-Fluoro-2-deoxy-D-Glucose Positron Emission Tomography Imaging in a Mouse Model of …

G Hugon, S Goutal, M Sarazin, M Bottlaender… - Frontiers in …, 2022 - frontiersin.org
Translational methods are needed to monitor the impact of the Alzheimer's disease (AD) and
therapies on brain function in animal models and patients. The formation of amyloid plaques …

Innovative approaches in CNS drug discovery

M Charveriat, V Lafon, F Mouthon, L Zimmer - Therapies, 2021 - Elsevier
Central nervous system disorders remain the leading causes of mortality and morbidity
worldwide, affecting more than 1 billion patients. This therapeutic area suffers from high …

Donepezil-based combination therapy for Alzheimer's disease and related neuropathies

BE Ekundayo, TO Obafemi, OB Adewale… - Comparative Clinical …, 2023 - Springer
Combination therapy has birthed improved treatment possibilities for a number of complex
and degenerative diseases in the world, which include cancer, diabetes and cardiovascular …

Subcommissural organ-spondin-derived peptide restores memory in a mouse model of Alzheimer's disease

J Le Douce, N Delétage, V Bourdès… - Frontiers in …, 2021 - frontiersin.org
Alzheimer's disease (AD) is a devastating neurodegenerative disease that affects millions of
older people worldwide and is characterized by a progressive deterioration of cognitive …

Pharmaco-fUS in cognitive impairment: lessons from a preclinical model

B Vidal, M Pereira, M Valdebenito… - Journal of …, 2022 - journals.sagepub.com
Background: There is an urgent need to understand and reverse cognitive impairment. The
lack of appropriate animal models combined with the limited knowledge of …